Clinical Trials

Our KiTZ Clinical Trial Unit (ZIPO) consists of a multidisciplinary team looking after young cancer patients for whom standard treatment procedures have not been successful. During clinical trials the team enables these children and adolescents to gain access to new treatment options under controlled conditions whenever possible. Further information you find here.

Today, most brain tumors in childhood and adolescence are in principle curable by combinations of surgery, chemotherapy and radiotherapy. About every fourth patient is still suffering from a relapse - a situation for which there are often no established treatment options. In order to find new treatment options for the affected patients, scientists of the preclinical program of the KiTZ analyse the tumor tissue using state-of-the-art methodologies for molecular target identification. Further information you find here.

Once children and adolescents suffer a disease relapse, despite first-line therapy and intensive pre-treatment, their chances of recovery are often limited ̶  especially in the case of solid tumors or brain tumors. Thanks to far-reaching developments in molecular genetic analysis and a large number of new so-called targeted drugs and immunotherapeutic approaches, we are confident to better help these children in the near future. Further unformation you find here.